Marc Carrier Selected Research

Dalteparin (Dalteparin Sodium)

12/2021	Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
1/2020	Clinical implications of incidental venous thromboembolism in cancer patients.
11/2019	Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
5/2019	Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study.
1/2019	Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants.
8/2018	Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
2/2018	Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
3/2017	Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
6/2013	Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Carrier Research Topics

Disease

83	Neoplasms (Cancer) 07/2022 - 01/2008
74	Venous Thromboembolism 10/2022 - 12/2002
72	Hemorrhage 07/2022 - 05/2010
42	Thrombosis (Thrombus) 01/2022 - 01/2003
24	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 01/2003
15	COVID-19 01/2022 - 01/2020
15	Pulmonary Embolism 01/2022 - 01/2006
12	Atrial Fibrillation 01/2022 - 09/2011
11	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2007
7	Critical Illness (Critically Ill) 01/2022 - 08/2016
6	Thromboembolism 01/2022 - 01/2018
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2020 - 12/2002
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 08/2018
3	Infections 01/2022 - 07/2020
3	Obesity 01/2022 - 01/2020
3	Subacute Sclerosing Panencephalitis (SSPE) 11/2020 - 12/2017
3	Neoplasm Metastasis (Metastasis) 11/2020 - 07/2013
3	Stroke (Strokes) 10/2015 - 06/2014
3	Pregnancy Complications 02/2014 - 06/2010
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 01/2022
2	Sepsis (Septicemia) 01/2022 - 06/2017
2	Inflammation (Inflammations) 01/2022 - 07/2021
2	Brain Neoplasms (Brain Tumor) 07/2021 - 11/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 12/2016
2	Embolism (Embolus) 11/2019 - 06/2014
2	Chronic Disease (Chronic Diseases) 01/2019 - 10/2018
2	Thrombophilia 03/2016 - 06/2010
2	Pre-Eclampsia (Preeclampsia) 07/2011 - 06/2010
2	Abruptio Placentae (Placental Abruption) 07/2011 - 06/2010
1	Wounds and Injuries (Trauma) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Morbid Obesity 01/2022
1	Overweight 12/2021
1	Varicose Veins (Varicose Vein) 12/2021
1	Ischemia 12/2021

Drug/Important Bio-Agent (IBA)

85	AnticoagulantsIBA 07/2022 - 02/2009
42	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 01/2003
23	apixabanIBA 01/2022 - 08/2013
19	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2003
17	RivaroxabanIBA 01/2022 - 08/2013
13	Vitamin K FDA Link 01/2022 - 08/2013
9	Pharmaceutical PreparationsIBA 03/2022 - 05/2014
9	edoxabanIBA 12/2021 - 06/2014
9	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 06/2013
9	fibrin fragment D (D-dimer)IBA 10/2021 - 01/2006
7	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 09/2009
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 06/2013
6	Dabigatran FDA Link 03/2021 - 08/2013
5	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2020
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 08/2013
4	Prothrombin (Factor II)IBA 03/2021 - 06/2010
4	Factor Xa InhibitorsIBA 01/2019 - 11/2015
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2021
3	CreatinineIBA 01/2022 - 07/2015
3	ORALIT (ORS)IBA 12/2021 - 06/2010
3	Fondaparinux (Arixtra)FDA Link 01/2021 - 09/2014
2	pro-brain natriuretic peptide (1-76)IBA 07/2022 - 04/2013
2	Troponin T (Troponin T1)IBA 07/2022 - 04/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2022 - 01/2022
2	VaccinesIBA 01/2022 - 01/2021
2	Fibrinogen (Factor I)FDA Link 07/2021 - 03/2021
2	Hemostatics (Antihemorrhagics)IBA 12/2020 - 11/2020
2	Asparaginase (Elspar)FDA Link 12/2020 - 01/2020
2	Neutralizing AntibodiesIBA 10/2020 - 07/2020
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2020 - 06/2014
2	AntithrombinsIBA 01/2020 - 01/2019
2	Nadroparin (Nadroparin Calcium)IBA 01/2020 - 12/2016
2	coumarinIBA 05/2019 - 07/2012
2	boldenone undecylenate (Equipoise)IBA 01/2017 - 01/2015
2	AntibodiesIBA 07/2011 - 01/2007
2	factor V LeidenIBA 06/2010 - 12/2002
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2022
1	Trinitrotoluene (TNT)IBA 07/2022
1	Verapamil (Calan)FDA LinkGeneric 03/2022
1	Diltiazem (Cardizem)FDA LinkGeneric 03/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 03/2022
1	Metoprolol (Toprol-XL)FDA LinkGeneric 03/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 03/2022
1	Cytochrome P-450 CYP3AIBA 03/2022
1	Aromatase InhibitorsIBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	EnzymesIBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022

Therapy/Procedure

55	Therapeutics 07/2022 - 01/2003
33	Drug Therapy (Chemotherapy) 10/2022 - 02/2012
6	Contraindications 01/2022 - 02/2012
6	Central Venous Catheters 01/2022 - 02/2015
5	Catheters 09/2017 - 09/2012
4	Duration of Therapy 07/2022 - 02/2012
4	Artificial Respiration (Mechanical Ventilation) 01/2022 - 10/2020
3	Secondary Prevention 04/2017 - 08/2013
2	Cystectomy 01/2022 - 01/2017
2	Immunotherapy 01/2022 - 01/2021
2	Erythrocyte Transfusion 03/2021 - 10/2020
2	Platelet Transfusion (Blood Platelet Transfusions) 12/2020 - 10/2018
2	Bariatric Surgery 01/2020 - 04/2014
1	Vena Cava Filters (Inferior Vena Cava Filter) 01/2022
1	Neoadjuvant Therapy 01/2022